Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 4.25 | 50.67 |
| PEG Ratio (TTM) | 0.09 | -8.93 |
| P/S Ratio (TTM) | 1.74 | 14.09 |
| P/B Ratio (TTM) | 1.22 | 12.78 |
| P/FCF Ratio (TTM) | -6.30 | 45.71 |
| Price to 5YR AVG Earnings Ratio | 22.88 | 70.15 |
| Price to 5YR AVG FCF Ratio | 32.62 | 75.18 |
Profitability (80%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.58% | -2.58% |
| ROE (TTM) | 33.80% | 6.65% |
| Net Profit Margin (TTM) | 40.62% | 3.92% |
| ROIC 5YR AVG | 11.75% | 4.82% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 126.56% | 34.41% | 49.47% |
| Revenue | 123.61% | -22.56% | -13.98% |
| Net Income | 126.65% | 40.40% | 55.53% |
| Cash Flow | -8.47% | 26,388.31% | 15,849.27% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.55 | 1.84 |
| Quick Ratio (TTM) | 0.72 | 2.10 |
| D/E Ratio (TTM) | 1.25 | 0.54 |
| Interest Coverage (TTM) | 12.68 | 10.64 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 0.87 | 9.11 |
| LTL to 5YR AVG FCF | N/A | 3.47 |
| Shares Outstanding Growth 5YR AVG | 0.81% | 57.49% |